(Reuters) – Biogen Inc and Japan’s Eisai Co Ltd said on Friday the U.S. Food and Drug Administration has granted an expedited review for the…
Home »
Biogen raises full-year profit view, quarter boosted by Tecfidera demand
(Reuters) – Drugmaker Biogen Inc (BIIB.O) beat analysts’ estimates for quarterly profit on Wednesday on better-than-expected sales of its multiple sclerosis treatment Tecfidera, and boosted…